Medirom Healthcare (MRM) | Stock Overview & Key Data
Medirom Healthcare Performance Comparison
Stock Range
Today's Range
Low: $1.99
High: $2.32
on October 3, 2025
52 Week Range
Low: $0.34
High: $5.30
on March 31, 2025
on October 16, 2024
All-Time High: $19.80 on December 28, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$22.7M
EPS
0.19
P/E Ratio (TTM)
10.79
Forward P/E
N/A
P/B Ratio
0.02
PEG Ratio
N/A
Div. Yield
N/A
ROE
22.96%
Beta
0.951
Debt to Equity
400.54
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
13.30%
Profit Margin
1.79%
Returns and Earnings
Return on Assets (TTM)
0.04%
Return on Equity (TTM)
22.96%
EBITDA
$2.4M
Net Income (TTM)
$1.0M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$1,050.28
Quarterly Revenue Growth (YoY)
31.20%
Quarterly Earnings Growth (YoY)
55.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Medirom Healthcare MRM | 22.68M Micro-cap | -30.27% | 31.41% | 45.39% | 197.10% | 102.97% | -24.63% | -65.83% | -85.76% |
| Rollins ROL | 28.60B Large-cap | 0.48% | 4.28% | 4.02% | 5.03% | 27.52% | 17.84% | 62.36% | 53.25% |
| Service SCI | 11.76B Large-cap | 2.13% | 7.49% | 2.54% | 3.05% | 8.29% | 10.10% | 39.77% | 86.60% |
| Medifast MED | 155.35M Micro-cap | 2.04% | 0.21% | -4.05% | 7.12% | -19.09% | -24.13% | -87.77% | -91.52% |
| Regis RGS | 74.66M Micro-cap | 3.28% | 22.89% | 27.61% | 69.32% | 24.65% | 8.39% | 35.69% | -78.87% |
| Yy Group Holding YYGH | 23.31M Micro-cap | 2.70% | -77.11% | -86.94% | -72.46% | -78.29% | -68.33% | -87.07% | -87.07% |
Ownership & Short Interest
Insider Ownership
26.42%
Institutional Ownership
1.48%
Shares Short
249K
Short Ratio
0.17
Short % of Shares Outstanding
3.81%
Average 10-Day Volume
10M
Average 90-Day Volume
4M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MRM's 52-week high and low?
- In the last 52 weeks, Medirom Healthcare reached a high of $5.30 (on October 16, 2024) and a low of $0.34 (on March 31, 2025).
- What is the market cap and P/E ratio for MRM?
- Curious about Medirom Healthcare's size and valuation? Its market capitalization stands at 22.68M. When it comes to valuation, the P/E ratio (trailing twelve months) is 10.79, and the forward P/E (looking ahead) is N/A.
- Does MRM pay dividends? If so, what's the yield?
- As for dividends, Medirom Healthcare isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medirom Healthcare's main competitors or similar companies to consider before investing?
When looking at Medirom Healthcare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Rollins
ROL28.60B Consumer Cyclical Personal Services 17.84% 62.36% Service
SCI11.76B Consumer Cyclical Personal Services 10.10% 39.77% Medifast
MED155.35M Consumer Cyclical Personal Services -24.13% -87.77% Regis
RGS74.66M Consumer Cyclical Personal Services 8.39% 35.69% Yy Group Holding
YYGH23.31M Consumer Cyclical Personal Services -68.33% -87.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medirom Healthcare Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medirom Healthcare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 22.96%, the Debt to Equity ratio from the most recent quarter is 400.54, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for MRM?
- Looking at Medirom Healthcare's growth, its revenue over the trailing twelve months (TTM) was $56M. Compared to the same quarter last year (YoY), quarterly revenue grew by 31.20%, and quarterly earnings saw a YoY growth of 55.40%.
- How much of MRM stock is held by insiders and institutions?
- Wondering who owns Medirom Healthcare stock? Company insiders (like executives and directors) hold about 26.42% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 1.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.